8Horiguchi J,Koibuchi Y,Lijima K,et al.Co-expressed type of ER an d HER2 protein asa predictive factor in determining resistance to antiestro-gen therapy in patients with ER-positive and HER2-positive breast cancer[J].Oncol Rep,2005,14(5):1109-1116.
9Giovanella L,Ceriani L,Giardian G,et al.Serum cytokeratin fragment 21.1(CYFRA21.1) as tumor marker for breast cancer:comparison with carbohydrate antigen 15.3(CA15.3) and carcinoembryonic antigen(CEA)[J].Clin Chem Lab Med,2002,40(3):298-303.